Angela Corpolongo
Overview
Explore the profile of Angela Corpolongo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
1041
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vita S, Bartoli T, Mariano A, Maffongelli G, Scorzolini L, Corpolongo A, et al.
Travel Med Infect Dis
. 2025 Jan;
64:102804.
PMID: 39874995
No abstract available.
2.
Mondi A, Mastrorosa I, Navarra A, Cimaglia C, Pinnetti C, Mazzotta V, et al.
Vaccines (Basel)
. 2024 Sep;
12(9).
PMID: 39340048
This is a retrospective observational study including all COVID-19 patients admitted at our Institute throughout three successive pandemic waves, from January 2021 to June 2023. The main in-hospital outcomes (clinical...
3.
Giancola M, Haggiag S, Corpolongo A, Stasolla A, Mariano A, Menniti A, et al.
Trop Med Infect Dis
. 2024 Aug;
9(8).
PMID: 39195625
Neurocysticercosis (NCC) is caused by the larval stage of . This parasitic disease is endemic in many areas of the world and is emerging in Europe. NCC can affect different...
4.
Giancola M, Angheben A, Scorzolini L, Carrara S, Petrone A, Vulcano A, et al.
Infect Dis Rep
. 2024 Aug;
16(4):650-663.
PMID: 39195001
Chagas disease (CD) is a parasitic infection endemic in Latin America and also affects patients in Western countries due to migration flows. This has a significant impact on health services...
5.
Tomassi M, DAbramo A, Vita S, Corpolongo A, Vulcano A, Bartoli T, et al.
Malar J
. 2024 Apr;
23(1):93.
PMID: 38575935
Background: Plasmodium ovale malaria is usually considered a tropical infectious disease associated with low morbidity and mortality. However, severe disease and death have previously been reported. Case Presentation: A case...
6.
DAbramo A, Rinaldi F, Vita S, Mazzieri R, Corpolongo A, Palazzolo C, et al.
Malar J
. 2024 Feb;
23(1):46.
PMID: 38351021
Background: The aim of this study is to design ad hoc malaria learning (ML) approaches to predict clinical outcome in all patients with imported malaria and, therefore, to identify the...
7.
Picchianti-Diamanti A, Navarra A, Aiello A, Lagana B, Cuzzi G, Salmi A, et al.
Vaccines (Basel)
. 2023 Nov;
11(11).
PMID: 38006015
: We aimed to analyse the incidence and severity of breakthrough infections (BIs) in rheumatoid arthritis (RA) patients after a COronaVIrus Disease 2019 (COVID-19) vaccination booster dose. : We enrolled...
8.
Vita S, Bordi L, Sberna G, Caputi P, Lapa D, Corpolongo A, et al.
Emerg Infect Dis
. 2023 Nov;
30(1):183-184.
PMID: 37967518
Since August 2023, outbreaks of dengue virus (DENV) infection have occurred in Italy. We report 2 autochthonous case-patients and their extended follow-up. Despite persistent DENV detected in blood by PCR,...
9.
Comelli A, Genovese C, Gobbi F, Brindicci G, Capone S, Corpolongo A, et al.
Infection
. 2023 Jul;
51(5):1249-1271.
PMID: 37420083
No abstract available.
10.
Bordi L, Sberna G, Lalle E, Fabeni L, Mazzotta V, Lanini S, et al.
Int J Mol Sci
. 2023 Mar;
24(5).
PMID: 36902277
To compare the detection of the SARS-CoV-2 Omicron variant in nasopharyngeal-swab (NPS) and oral saliva samples. 255 samples were obtained from 85 Omicron-infected patients. SARS-CoV-2 load was measured in the...